Role of cholesterol in the function and organization of G-protein coupled receptors

Progress in Lipid Research

Volumn 45, Issue 4, 2006, Pages 295-333

  Pucadyil, Thomas J ^a   Chattopadhyay, Amitabha ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Cholesterol; G protein coupled receptors; Lipid protein interactions; Serotonin1A receptors

Indexed keywords

CHOLESTEROL; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; SEROTONIN 1A RECEPTOR;

BIOAVAILABILITY; BIOCHEMISTRY; BIODIVERSITY; BRAIN REGION; CELL MEMBRANE; CELL SURFACE; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; ENZYME METABOLISM; HEALTH; HIPPOCAMPUS; INHIBITION KINETICS; MEMBRANE; MEMBRANE BIOLOGY; MEMBRANE POTENTIAL; MEMBRANE STRUCTURE; MODULATION; MOLECULAR DYNAMICS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALS; CELL MEMBRANE; CHOLESTEROL; HUMANS; LIPID METABOLISM; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EUKARYOTA; MAMMALIA;

EID: 33744543610     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2006.02.002     Document Type: Review

References (348)

1. Tanford C. The hydrophobic effect and the organization of living matter. Science 200 (1978) 1012-1018
2. Gennis R.B. Biomembranes. Molecular structure and function (1989), Springer-Verlag, New York
3. Marsh D., Horvath L.I., Swamy M.J., Mantripragada S., and Kleinschmidt J.H. Interaction of membrane-spanning proteins with peripheral and lipid-anchored membrane proteins: perspectives from protein-lipid interactions. Mol Membr Biol 19 (2002) 247-255
4. Chattopadhyay A. Exploring membrane organization and dynamics by the wavelength-selective fluorescence approach. Chem Phys Lipids 122 (2003) 3-17
5. Edidin M. Lipids on the frontier: a century of cell-membrane bilayers. Nat Rev Mol Cell Biol 4 (2003) 414-418
6. Dowhan W. Molecular basis for membrane phospholipid diversity: why are there so many lipids?. Annu Rev Biochem 66 (1997) 199-232
7. White S.H., Ladokhin A.S., Jayasinghe S., and Hristova K. How membranes shape protein structure. J Biol Chem 276 (2001) 32395-32398
8. Lee A.G. How lipids affect the activities of integral membrane proteins. Biochim Biophys Acta 1666 (2004) 62-87
9. Wallin E., and von Heijne G. Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. Protein Sci 7 (1998) 1029-1038
10. Liu Y., Engelman D.M., and Gerstein M. Genomic analysis of membrane protein families: abundance and conserved motifs. Genome Biol 3 (2002) 1-12
11. Drews J. Drug discovery: a historical perspective. Science 287 (2000) 1960-1964
12. Perez D.M. The evolutionarily triumphant G-protein-coupled receptor. Mol Pharmacol 63 (2003) 1202-1205
13. Pierce K.L., Premont R.T., and Lefkowitz R.J. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3 (2002) 639-650
14. Liscum L., and Underwood K.W. Intracellular cholesterol transport and compartmentation. J Biol Chem 270 (1995) 15443-15446
15. Simons K., and Ikonen E. How cells handle cholesterol. Science 290 (2000) 1721-1726
16. Mouritsen O.G., and Zuckermann M.J. What's so special about cholesterol?. Lipids 39 (2004) 1101-1113
17. Harris J.S., Epps D.E., Davio S.R., and Kezdy F.J. Evidence for transbilayer, tail-to-tail cholesterol dimers in dipalmitoylglycerophosphocholine liposomes. Biochemistry 34 (1995) 3851-3857
18. Mukherjee S., and Chattopadhyay A. Membrane organization at low cholesterol concentrations: a study using 7-nitrobenz-2-oxa-1,3-diazol-4-yl-labeled cholesterol. Biochemistry 35 (1996) 1311-1322
19. Loura L.M., and Prieto M. Dehydroergosterol structural organization in aqueous medium and in a model system of membranes. Biophys J 72 (1997) 2226-2236
20. Tulenko T.N., Chen M., Mason P.E., and Mason R.P. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. J Lipid Res 39 (1998) 947-956
21. Rukmini R., Rawat S.S., Biswas S.C., and Chattopadhyay A. Cholesterol organization in membranes at low concentrations: effects of curvature stress and membrane thickness. Biophys J 81 (2001) 2122-2134
22. Mason R.P., Tulenko T.N., and Jacob R.F. Direct evidence for cholesterol crystalline domains in biological membranes: role in human pathobiology. Biochim Biophys Acta 1610 (2003) 198-207
23. Yeagle P.L. Cholesterol and the cell membrane. Biochim Biophys Acta 822 (1985) 267-287
24. Houslay M.D., and Stanley K.K. Dynamics of biological membranes (1982), Wiley-InterScience, New York
25. Ipsen J.H., Karlström G., Mouritsen O.G., Wennerström H., and Zuckermann M.J. Phase equilibria in the phosphatidylcholine-cholesterol system. Biochim Biophys Acta 905 (1987) 162-172
26. Sankaram M.B., and Thompson T.E. Interaction of cholesterol with various glycerophospholipids and sphingomyelin. Biochemistry 29 (1990) 10670-10675
27. Rubenstein J.L., Smith B.A., and McConnell H.M. Lateral diffusion in binary mixtures of cholesterol and phosphatidylcholines. Proc Natl Acad Sci USA 76 (1979) 15-18
28. Mitchell D.C., and Litman B.J. Effect of cholesterol on molecular order and dynamics in highly polyunsaturated phospholipid bilayers. Biophys J 75 (1998) 896-908
29. Niu S.L., and Litman B.J. Determination of membrane cholesterol partition coefficient using a lipid vesicle-cyclodextrin binary system: effect of phospholipid acyl chain unsaturation and headgroup composition. Biophys J 83 (2002) 3408-3415
30. Silvius J.R. Role of cholesterol in lipid raft formation: lessons from lipid model systems. Biochim Biophys Acta 1610 (2003) 174-183
31. McConnell H.M., and Radhakrishnan A. Condensed complexes of cholesterol and phospholipids. Biochim Biophys Acta 1610 (2003) 159-173
32. Veatch S.L., and Keller S.L. Separation of liquid phases in giant vesicles of ternary mixtures of phospholipids and cholesterol. Biophys J 85 (2003) 3074-3083
33. Korlach J., Schwille P., Webb W.W., and Feigenson G.W. Characterization of lipid bilayer phases by confocal microscopy and fluorescence correlation spectroscopy. Proc Natl Acad Sci USA 96 (1999) 8461-8466
34. Dietrich C., Bagatolli L.A., Volovyk Z.N., Thompson N.L., Levi M., Jacobson K., et al. Lipid rafts reconstituted in model membranes. Biophys J 80 (2001) 1417-1428
35. Ohvo-Rekilä H., Ramstedt B., Leppimäki P., and Slotte J.P. Cholesterol interactions with phospholipids in membranes. Prog Lipid Res 41 (2002) 66-97
36. Schroeder F., Woodford J.K., Kavecansky J., Wood W.G., and Joiner C. Cholesterol domains in biological membranes. Mol Membr Biol 12 (1995) 113-119
37. Schroeder F., Frolov A.A., Murphy E.J., Atshaves B.P., Jefferson J.R., Pu L., et al. Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking. Proc Soc Exp Biol Med 213 (1996) 150-177
38. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
39. Xu X., and London E. The effect of sterol structure on membrane lipid domains reveals how cholesterol can induce lipid domain formation. Biochemistry 39 (2000) 843-849
40. Tashiro Y., Yamazaki T., Shimada Y., Ohno-Iwashita Y., and Okamoto K. Axon-dominant localization of cell-surface cholesterol in cultured hippocampal neurons and its disappearance in Niemann-Pick type C model cells. Eur J Neurosci 20 (2004) 2015-2021
41. Simons K., and van Meer G. Lipid sorting in epithelial cells. Biochemistry 27 (1988) 6197-6202
42. Maxfield F.R., and Wustner D. Intracellular cholesterol transport. J Clin Invest 110 (2002) 891-898
43. Lange Y., and Ramos B.V. Analysis of the distribution of cholesterol in the intact cell. J Biol Chem 258 (1983) 15130-15134
44. Lange Y. Disposition of intracellular cholesterol in human fibroblasts. J Lipid Res 32 (1991) 329-339
45. Holthuis J.C., Pomorski T., Raggers R.J., Sprong H., and Van Meer G. The organizing potential of sphingolipids in intracellular membrane transport. Physiol Rev 81 (2001) 1689-1723
46. Anderson R.G.W. The caveolae membrane system. Annu Rev Biochem 67 (1998) 199-225
47. London E., and Brown D.A. Insolubility of lipids in triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 1508 (2000) 182-195
48. London E. Insights into lipid raft structure and formation from experiments in model membranes. Curr Opin Struct Biol 12 (2002) 480-486
49. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1 (2000) 31-39
50. van der Goot F.G., and Harder T. Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 13 (2001) 89-97
51. Simons K., and Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 110 (2002) 597-603
52. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
53. Rietveld A., and Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim Biophys Acta 1376 (1998) 467-479
54. Pucadyil T.J., and Chattopadhyay A. Exploring detergent insolubility in bovine hippocampal membranes: a critical assessment of the requirement for cholesterol. Biochim Biophys Acta 1661 (2004) 9-17
55. Veiga M.P., Arrondo J.L.R., Goñi F.M., Alonso A., and Marsh D. Interaction of cholesterol with sphingomyelin in mixed membranes containing phosphatidylcholine, studied by spin-label ESR and IR spectroscopies. A possible stabilization of gel-phase sphingolipid domains by cholesterol. Biochemistry 40 (2001) 2614-2622
56. Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 32 (2003) 257-283
57. Munro S. Lipid rafts: elusive or illusive?. Cell 115 (2003) 377-388
58. Lommerse P.H., Spaink H.P., and Schmidt T. In vivo plasma membrane organization: results of biophysical approaches. Biochim Biophys Acta 1664 (2004) 119-131
59. Mayor S., and Rao M. Rafts: scale-dependent, active lipid organization at the cell surface. Traffic 5 (2004) 231-240
60. Kusumi A., Ike H., Nakada C., Murase K., and Fujiwara T. Single-molecule tracking of membrane molecules: plasma membrane compartmentalization and dynamic assembly of raft-philic signaling molecules. Semin Immunol 17 (2005) 3-21
61. Lagerholm B.C., Weinreb G.E., Jacobson K., and Thompson N.L. Detecting microdomains in intact cell membranes. Annu Rev Phys Chem 56 (2005) 309-336
62. Tabas I. Cholesterol in health and disease. J Clin Invest 110 (2002) 583-590
63. Porter F.D. Malformation syndromes due to inborn errors of cholesterol synthesis. J Clin Invest 110 (2002) 715-724
64. Tobert J.A. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov 2 (2003) 517-526
65. Härtel S., Diehl H.A., and Ojeda F.S. Methyl-β-cyclodextrins and liposomes as water-soluble carriers for cholesterol incorporation into membranes and its evaluation by a microenzymatic fluorescence assay and membrane fluidity-sensitive dyes. Anal Biochem 258 (1998) 277-284
66. Ottico E., Prinetti A., Prioni S., Giannotta C., Basso L., Chigorno V., et al. Dynamics of membrane lipid domains in neuronal cells differentiated in culture. J Lipid Res 44 (2003) 2142-2151
67. Ohtani Y., Irie T., Uekama K., Fukunaga K., and Pitha J. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem 186 (1989) 17-22
68. Tanhuanpää K., and Somerharju P. γ-Cyclodextrins greatly enhance translocation of hydrophobic fluorescent phospholipids from vesicles to cells in culture. Importance of molecular hydrophobicity in phospholipid trafficking studies. J Biol Chem 274 (1999) 35359-35366
69. Nishijo J., Shiota S., Mazima K., Inoue Y., Mizuno H., and Yoshida J. Interactions of cyclodextrins with dipalmitoyl, distearoyl, and dimyristoyl phosphatidyl choline liposomes. A study by leakage of carboxyfluorescein in inner aqueous phase of unilamellar liposomes. Chem Pharm Bull 48 (2000) 48-52
70. Kilsdonk E.P., Yancey P.G., Stoudt G.W., Bangerter F.W., Johnson W.J., Phillips M.C., et al. Cellular cholesterol efflux mediated by cyclodextrins. J Biol Chem 270 (1995) 17250-17256
71. Tsamaloukas A., Szadkowska H., Slotte J.P., and Heerklotz H. Interactions of cholesterol with lipid membranes and cyclodextrin characterized by calorimetry. Biophys J 89 (2005) 1109-1119
72. 1A receptors from bovine hippocampus. Biochim Biophys Acta 1663 (2004) 188-200
73. Anderson T.G., Tan A., Ganz P., and Seelig J. Calorimetric measurement of phospholipid interaction with methyl-β-cyclodextrin. Biochemistry 43 (2004) 2251-2261
74. Christian A.E., Haynes M.P., Phillips M.C., and Rothblat G.H. Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res 38 (1997) 2264-2272
75. Rothblat G.H., de la Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., and Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 40 (1999) 781-796
76. Atger V.M., de la Llera Moya M., Stoudt G.W., Rodrigueza W.V., Phillips M.C., and Rothblat G.H. Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 99 (1997) 773-780
77. Gimpl G., Burger K., and Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry 36 (1997) 10959-10974
78. Leventis R., and Silvius J.R. Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol. Biophys J 81 (2001) 2257-2267
79. John K., Kubelt J., Muller P., Wustner D., and Herrmann A. Rapid transbilayer movement of the fluorescent sterol dehydroergosterol in lipid membranes. Biophys J 83 (2002) 1525-1534
80. Brown A.J., Sun L., Feramisco J.D., Brown M.S., and Goldstein J.L. Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 10 (2002) 237-245
81. Hao M., Mukherjee S., and Maxfield F.R. Cholesterol depletion induces large scale domain segregation in living cell membranes. Proc Natl Acad Sci USA 98 (2001) 13072-13077
82. Yancey P.G., Rodrigueza W.V., Kilsdonk E.P., Stoudt G.W., Johnson W.J., Phillips M.C., et al. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J Biol Chem 271 (1996) 16026-16034
83. Pitha J., Irie T., Sklar P.B., and Nye J.S. Drug solubilizers to aid pharmacologists: amorphous cyclodextrin derivatives. Life Sci 43 (1988) 493-502
84. Riottot M., Olivier P., Huet A., Caboche J.J., Parquet M., Khallou J., et al. Hypolipidemic effects of beta-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat. Lipids 28 (1993) 181-188
85. Khanna K.V., Whaley K.J., Zeitlin L., Moench T.R., Mehrazar K., Cone R.A., et al. Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 109 (2002) 205-211
86. Elias P.M., Goerke J., Friend D.S., and Brown B.E. Freeze-fracture identification of sterol-digitonin complexes in cell and liposome membranes. J Cell Biol 78 (1978) 577-596
87. Nishikawa M., Nojima S., Akiyama T., Sankawa U., and Inoue K. Interaction of digitonin and its analogs with membrane cholesterol. J Biochem 96 (1984) 1231-1239
88. 1A receptor. Mol Membr Biol 22 (2005) 241-249
89. Severs N.J., and Robenek H. Detection of microdomains in biomembranes: an appraisal of recent developments in freeze-fracture cytochemistry. Biochim Biophys Acta 737 (1983) 373-408
90. Akiyama T., Takagi S., Sankawa U., Inari S., and Saitô H. Saponin-cholesterol interaction in the multibilayers of egg yolk lecithin as studied by deuterium nuclear magnetic resonance: digitonin and its analogues. Biochemistry 19 (1980) 1904-1911
91. Dontchev V., Ichev K., Ovtscharoff W., and Surchev L. Light and electron microscopic demonstration of cholesterol distribution in membrane structures of the rat auditory cortex. Acta Histochem 96 (1994) 165-174
92. Boesze-Battaglia K., Hennessey T., and Albert A.D. Cholesterol heterogeneity in bovine rod outer segment disk membranes. J Biol Chem 264 (1989) 8151-8155
93. Holz R.W. The effects of the polyene antibiotics nystatin and amphotericin B on thin lipid membranes. Ann NY Acad Sci 235 (1974) 469-479
94. Marty A., and Finkelstein A. Pores formed in lipid bilayer membranes by nystatin: differences in its one-sided and two-sided action. J Gen Physiol 65 (1975) 515-526
95. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties?. Biochim Biophys Acta 864 (1986) 257-304
96. Coutinho A., and Prieto M. Cooperative partition model of nystatin interaction with phospholipid vesicles. Biophys J 84 (2003) 3061-3078
97. de Kruijff D., and Demel R.A. Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes III. Molecular structure of the polyene antibiotic cholesterol complexes. Biochim Biophys Acta 339 (1974) 57-70
98. Coutinho A., Silva L., Fedorov A., and Prieto M. Cholesterol and ergosterol influence nystatin surface aggregation: relation to pore formation. Biophys J 87 (2004) 3264-3276
99. Sampson N.S., and Vrielink A. Cholesterol oxidases: a study of nature's approach to protein design. Acc Chem Res 36 (2003) 713-722
100. Bittman R., Kasireddy C.R., Mattjus P., and Slotte J.P. Interaction of cholesterol with sphingomyelin in monolayers and vesicles. Biochemistry 33 (1994) 11776-11781
101. Samsonov A.V., Mihalyov I., and Cohen F.S. Characterization of cholesterol-sphingomyelin domains and their dynamics in bilayer membranes. Biophys J 81 (2001) 1486-1500
102. el Yandouzi E.H., and Le Grimellec C. Effect of cholesterol oxidase treatment on the physical state of renal brush border membranes: evidence for a cholesterol pool interacting weakly with membrane lipids. Biochemistry 32 (1993) 2047-2052
103. Wang M.M., Olsher M., Sugar I.P., and Chong P.L.-G. Cholesterol superlattice modulates the activity of cholesterol oxidase in lipid membranes. Biochemistry 43 (2004) 2159-2166
104. Ahn K.-W., and Sampson N.S. Cholesterol oxidase senses subtle changes in lipid bilayer structure. Biochemistry 43 (2004) 827-836
105. el Yandouzi E.H., and Le Grimellec C. Cholesterol heterogeneity in the plasma membrane of epithelial cells. Biochemistry 31 (1992) 547-551
106. Brown M.S., and Goldstein J.L. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 21 (1980) 505-517
107. Alberts A.W., Chen J., Kuron G., Hunt V., Huff J., Hoffman C., et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77 (1980) 3957-3961
108. Endo A., Tsujita Y., Kuroda M., and Tanzawa K. Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Eur J Biochem 77 (1977) 31-36
109. Istvan E.S., and Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292 (2001) 1160-1164
110. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
111. Kovanen P.T., Bilheimer D.W., Goldstein J.L., Jaramillo J.J., and Brown M.S. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci USA 78 (1981) 1194-1198
112. Ma P.T., Gil G., Sudhof T.C., Bilheimer D.W., Goldstein J.L., and Brown M.S. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci USA 83 (1986) 8370-8374
113. Rothberg K.G., Ying Y.-S., Kamen B.A., and Anderson R.G.W. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol 111 (1990) 2931-2938
114. Hua X., Sakai J., Brown M.S., and Goldstein J.L. Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane. J Biol Chem 271 (1996) 10379-10384
115. Burger K., Gimpl G., and Fahrenholz F. Regulation of receptor function by cholesterol. Cell Mol Life Sci 57 (2000) 1577-1592
116. Gimpl G., Burger K., and Fahrenholz F. A closer look at the cholesterol sensor. Trends Biochem Sci 27 (2002) 596-599
117. Hua X., Nohturfft A., Goldstein J.L., and Brown M.S. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell 87 (1996) 415-426
118. Kuwabara P.E., and Labouesse M. The sterol-sensing domain: multiple families, a unique role?. Trends Genet 18 (2002) 193-201
119. Radhakrishnan A., Sun L.P., Kwon H.J., Brown M.S., and Goldstein J.L. Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain. Mol Cell 15 (2004) 259-268
120. Barrantes F.J. Structural basis for lipid modulation of nicotinic acetylcholine receptor function. Brain Res Brain Res Rev 47 (2004) 71-95
121. Blanton M.P., and Wang H.H. Photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor with an aryl azide derivative of phosphatidylserine. Biochemistry 29 (1990) 1186-1194
122. Criado M., Eibl H., and Barrantes F.J. Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry 21 (1982) 3622-3629
123. Fong T.M., and McNamee M.G. Correlation between acetylcholine receptor function and structural properties of membranes. Biochemistry 25 (1986) 830-840
124. Sunshine C., and McNamee M.G. Lipid modulation of nicotinic acetylcholine receptor function: the role of neutral and negatively charged lipids. Biochim Biophys Acta 1108 (1992) 240-246
125. Jones O.T., and McNamee M.G. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry 27 (1988) 2364-2374
126. Addona G.H., Sandermann Jr. H., Kloczewiak M.A., Husain S.S., and Miller K.W. Where does cholesterol act during activation of the nicotinic acetylcholine receptor?. Biochim Biophys Acta 1370 (1998) 299-309
127. A receptor. Br J Pharmacol 117 (1996) 87-92
128. A currents by neurosteroids in dissociated hippocampal neurones. Neuropharmacology 37 (1998) 1103-1110
129. A receptor by neuroactive steroids and other potentiators. Br J Pharmacol 134 (2001) 1303-1311
130. Nunez M.T., and Glass J. Reconstitution of the transferrin receptor in lipid vesicles. Effect of cholesterol on the binding of transferrin. Biochemistry 21 (1982) 4139-4143
131. Fredriksson R., Lagerström M.C., Lundin L.-G., and Schiöth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63 (2003) 1256-1272
132. Kolakowski Jr. L.F. GCRDb: a G-protein coupled receptor database. Receptors Channels 2 (1994) 1-7
133. Karnik S.S., Gogonea S., Patil S., Saad Y., and Takezako T. Activation of G-protein-coupled receptors: a common molecular mechanism. Trends Endocrinol Metab 14 (2003) 431-437
134. Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol 6 (1994) 180-190
135. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80 (1995) 249-257
136. Hamm H.E. How activated receptors couple to G proteins. Proc Natl Acad Sci USA 98 (2001) 4819-4821
137. Cabrera-Vera T.M., Vanhauwe J., Thomas T.O., Medkova M., Preininger A., Mazzoni M.R., et al. Insights into G protein structure, function, and regulation. Endocr Rev 24 (2003) 765-781
138. αi-specific region. J Biol Chem 280 (2005) 24584-24590
139. Ji T.H., Grossmann M., and Ji I. G-protein coupled receptors. I Diversity of receptor-ligand interactions. J Biol Chem 273 (1998) 17299-17302
140. Hall R.A., Premont R.T., and Lefkowitz R.J. Heptahelical receptor signaling: beyond the G-protein paradigm. J Cell Biol 145 (1999) 927-932
141. Ostermeier C., and Michel H. Crystallization of membrane proteins. Curr Opin Struct Biol 7 (1997) 697-701
142. Caffrey M. A lipid's eye view of membrane protein crystallization in mesophases. Curr Opin Struct Biol 10 (2000) 486-497
143. Schertler G.F., Villa C., and Henderson R. Projection structure of rhodopsin. Nature 362 (1993) 770-772
144. Unger V.M., and Schertler G.F. Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. Biophys J 68 (1995) 1776-1786
145. Unger V.M., Hargrave P.A., Baldwin J.M., and Schertler G.F. Arrangement of rhodopsin transmembrane α-helices. Nature 389 (1997) 203-206
146. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
147. Teller D.C., Okada T., Behnke C.A., Palczewski K., and Stenkamp R.E. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40 (2001) 7761-7772
148. Okada T., and Palczewski K. Crystal structure of rhodopsin: implications for vision and beyond. Curr Opin Struct Biol 11 (2001) 420-426
149. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21 (2000) 90-113
150. Parnot C., Miserey-Lenkei S., Bardin S., Corvol P., and Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 13 (2002) 336-343
151. Cotecchia S., Fanelli F., and Costa T. Constitutively active G protein-coupled receptor mutants: implications on receptor function and drug action. Assay Drug Dev Technol 1 (2003) 311-316
152. Kjelsberg M.A., Cotecchia S., Ostrowski J., Caron M.G., and Lefkowitz R.J. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J Biol Chem 267 (1992) 1430-1433
153. Gether U., Ballesteros J.A., Seifert R., Sanders-Bush E., Weinstein H., and Kobilka B.K. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272 (1997) 2587-2590
154. Rasmussen S.G., Jensen A.D., Liapakis G., Ghanouni P., Javitch J.A., and Gether U. Mutation of a highly conserved aspartic acid in the β2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol Pharmacol 56 (1999) 175-184
155. Leurs R., Smit M.J., Alewijnse A.E., and Timmerman H. Agonist-independent regulation of constitutively active G-protein-coupled receptors. Trends Biochem Sci 23 (1998) 418-422
156. Arnis S., Fahmy K., Hofmann K.P., and Sakmar T.P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J Biol Chem 269 (1994) 23879-23881
157. Farrens D.L., Altenbach C., Yang K., Hubbell W.L., and Khorana H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 274 (1996) 768-770
158. 2 adrenoceptor. EMBO J 16 (1997) 6737-6747
159. De Lean A., Stadel J.M., and Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255 (1980) 7108-7117
160. Leff P. The two-state model of receptor activation. Trends Pharmacol Sci 16 (1995) 89-97
161. Flower D.R. Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1422 (1999) 207-234
162. Hopkins A.L., and Groom C.R. The druggable genome. Nat Rev Drug Discov 1 (2002) 727-730
163. Edwards S.W., Tan C.M., and Limbird L.E. Localization of G-protein-coupled receptors in health and disease. Trends Pharmacol Sci 21 (2000) 304-308
164. Robinson P.R., Cohen G.B., Zhukovsky E.A., and Oprian D.D. Constitutively active mutants of rhodopsin. Neuron 9 (1992) 719-725
165. Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365 (1993) 649-651
166. Shenker A., Laue L., Kosugi S., Merendino Jr. J.J., Minegishi T., and Cutler Jr. G.B. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365 (1993) 652-654
167. Sodhi A., Montaner A., and Gutkind J.S. Viral hijacking of G-protein-coupled-receptor signaling networks. Nat Rev Mol Cell Biol 5 (2004) 998-1012
168. Murphy P.M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nature Immunol 2 (2001) 116-122
169. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86 (1996) 367-377
170. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382 (1996) 722-725
171. Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M.C., and Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385 (1997) 347-350
172. Bais C., Santomasso B., Coso O., Arvanitakis L., Raaka E.G., Gutkind J.S., et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391 (1998) 86-89
173. Waldhoer M., Kledal T.N., Farrell H., and Schwartz T.W. Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 76 (2002) 8161-8168
174. Bodaghi B., Jones T.R., Zipeto D., Vita C., Sun L., Laurent L., et al. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188 (1998) 855-866
175. Elphick G.F., Querbes W., Jordan J.A., Gee G.V., Eash S., Manley K., et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306 (2004) 1380-1383
176. Harrison T., Samuel B.U., Akompong T., Hamm H., Mohandas N., Lomasney J.W., et al. Erythrocyte G protein-coupled receptor signaling in malarial infection. Science 301 (2003) 1734-1736
177. Huber T., Botelho A.V., Beyer K., and Brown M.F. Membrane model for the G-protein-coupled receptor rhodopsin: hydrophobic interface and dynamical structure. Biophys J 86 (2004) 2078-2100
178. Jones O.T., Eubanks J.H., Earnest J.P., and McNamee M.G. A minimum number of lipids are required to support the functional properties of the nicotinic acetylcholine receptor. Biochemistry 27 (1988) 3733-3742
179. Cerione R.A., Strulovici B., Benovic J.L., Strader C.D., Caron M.G., and Lefkowitz R.J. Reconstitution of β-adrenergic receptors in lipid vesicles: affinity chromatography-purified receptors confer catecholamine responsiveness on a heterologous adenylate cyclase system. Proc Natl Acad Sci USA 80 (1983) 4899-4903
180. Kirilovsky J., and Schramm M. Delipidation of a β-adrenergic receptor preparation and reconstitution by specific lipids. J Biol Chem 258 (1983) 6841-6849
181. Helenius A., and Simons K. Solubilization of membranes by detergents. Biochim Biophys Acta 415 (1975) 29-79
182. Silvius J.R. Solubilization and functional reconstitution of biomembrane components. Annu Rev Biophys Biomol Struct 21 (1992) 323-348
183. 1A receptors. IUMBM Life 57 (2005) 505-512
184. Banerjee P., Buse J.T., and Dawson G. Asymmetric extraction of membrane lipids by CHAPS. Biochim Biophys Acta 1044 (1990) 305-314
185. Banerjee P., Joo J.B., Buse J.T., and Dawson G. Differential solubilization of lipids along with membrane proteins by different classes of detergents. Chem Phys Lipids 77 (1995) 65-78
186. Mitchell D.C., Niu S.L., and Litman B.J. Enhancement of G protein-coupled signaling by DHA phospholipids. Lipids 38 (2003) 437-443
187. Alves I.D., Salgado G.F.J., Salamon Z., Brown M.F., Tollin G., and Hruby V.J. Phosphatidylethanolamine enhances rhodopsin photoactivation and transducin binding in a solid supported lipid bilayer as determined using plasmon-waveguide resonance spectroscopy. Biophys J 88 (2005) 198-210
188. Escribá P.V., Ozaita A., Ribas C., Miralles A., Fodor E., Farkas T., et al. Role of lipid polymorphism in G protein-membrane interactions: nonlamellar-prone phospholipids and peripheral protein binding to membranes. Proc Natl Acad Sci USA 94 (1997) 11375-11380
189. Yang Q., Alemany R., Casas J., Kitajka K., Lanier S.M., and Escribá P.V. Influence of the membrane lipid structure on signal processing via G protein-coupled receptors. Mol Pharmacol 68 (2005) 210-217
190. Qanbar R., and Bouvier M. Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol Ther 97 (2003) 1-33
191. Resh M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1451 (1999) 1-16
192. 3H]palmitic acid. J Biol Chem 259 (1984) 5054-5057
193. Ovchinnikov Y.A., Abdulaev N.G., and Bogachuk A.S. Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated. FEBS Lett 230 (1988) 1-5
194. Moench S.J., Moreland J., Stewart D.H., and Dewey T.G. Fluorescence studies of the location and membrane accessibility of the palmitoylation sites of rhodopsin. Biochemistry 33 (1994) 5791-5796
195. Chen C., Shahabi V., Xu W., and Liu-Chen L.Y. Palmitoylation of the rat μ opioid receptor. FEBS Lett 441 (1998) 148-152
196. Singer S.J., and Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science 175 (1972) 720-731
197. Liebman P.A., and Entine G. Lateral diffusion of visual pigment in photoreceptor disk membranes. Science 185 (1974) 457-459
198. Poo M., and Cone R.A. Lateral diffusion of rhodopsin in the photoreceptor membrane. Nature 247 (1974) 438-441
199. Jacobson K., Sheets E.D., and Simson R. Revisiting the fluid mosaic model of membranes. Science 268 (1995) 1441-1442
200. Mukherjee S., and Maxfield F.R. Membrane domains. Annu Rev Cell Dev Biol 20 (2004) 839-866
201. Pike L.J. Lipid rafts: bringing order to chaos. J Lipid Res 44 (2003) 655-667
202. Peters R. Lateral mobility of proteins and lipids in the red cell membrane and the activation of adenylate cyclase by beta-adrenergic receptors. FEBS Lett 234 (1988) 1-7
203. 2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature. EMBO J 8 (1989) 2481-2488
204. Zakharova O.M., Rosenkranz A.A., and Sobolev A.S. Modification of fluid lipid and mobile protein fractions of reticulocyte plasma membranes affects agonist-stimulated adenylate cyclase. Application of the percolation theory. Biochim Biophys Acta 1236 (1995) 177-184
205. Calvert P.D., Govardovskii V.I., Krasnoperova N., Anderson R.E., Lem J., and Makino C.L. Membrane protein diffusion sets the speed of rod phototransduction. Nature 411 (2001) 90-94
206. Stickle D., and Barber R. Collisions and encounters in simulations of receptor/GTP-binding protein interactions via simple diffusion. Biochim Biophys Acta 1310 (1996) 242-250
207. Neubig R.R. Membrane organization in G-protein mechanisms. FASEB J 8 (1994) 939-946
208. Hur E.-M., and Kim K.-T. G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity. Cell Signal 14 (2002) 397-405
209. Ostrom R.S., and Insel P.A. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 143 (2004) 235-245
210. Ostrom R.S., Gregorian C., Drenan R.M., Xiang Y., Regan J.W., and Insel P.A. Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem 276 (2001) 42063-42069
211. Rybin V.O., Xu X., Lisanti M.P., and Steinberg S.F. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 275 (2000) 41447-41457
212. Navratil A.M., Bliss S.P., Berghorn K.A., Haughian J.M., Farmerie T.A., Graham J.K., et al. Constitutive localization of the gonadotropin-releasing hormone (GnRH) receptor to low density membrane microdomains is necessary for GnRH signaling to ERK. J Biol Chem 278 (2003) 31593-31602
213. Nelson S., Horvat R.D., Malvey J., Roess D.A., Barisas B.G., and Clay C.M. Characterization of an intrinsically fluorescent gonadotropin-releasing hormone receptor and effects of ligand binding on receptor lateral diffusion. Endocrinology 140 (1999) 950-957
214. Horvat R.D., Roess D.A., Nelson S.E., Barisas B.G., and Clay C.M. Binding of agonist but not antagonist leads to fluorescence resonance energy transfer between intrinsically fluorescent gonadotropin-releasing hormone receptors. Mol Endocrinol 15 (2001) 695-703
215. Gimpl G., and Fahrenholz F. Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur J Biochem 267 (2000) 2483-2497
216. Guzzi F., Zanchetta D., Cassoni P., Guzzi V., Francolini M., Parenti M., et al. Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. Oncogene 21 (2002) 1658-1667
217. Chini B., and Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?. J Mol Endocrinol 32 (2004) 325-338
218. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275 (2000) 17221-17224
219. Melkonian K.A., Chu T., Tortorella L.B., and Brown D.A. Characterization of proteins in detergent-resistant membrane complexes from Madin-Darby canine kidney epithelial cells. Biochemistry 34 (1995) 16161-16170
220. Moffett S., Brown D.A., and Linder M.E. Lipid-dependent targeting of G proteins into rafts. J Biol Chem 275 (2000) 2191-2198
221. Wang T.Y., Leventis R., and Silvius J.R. Fluorescence-based evaluation of the partitioning of lipids and lipidated peptides into liquid-ordered lipid microdomains: a model for molecular partitioning into "lipid rafts". Biophys J 79 (2000) 919-933
222. Wang T.Y., Leventis R., and Silvius J.R. Partitioning of lipidated peptide sequences into liquid-ordered lipid domains in model and biological membranes. Biochemistry 40 (2001) 13031-13040
223. Jensen M.O., and Mouritsen O.G. Lipids do influence protein function - the hydrophobic matching hypothesis revisited. Biochim Biophys Acta 1666 (2004) 205-226
224. Alves I.D., Salamon Z., Hruby V.J., and Tollin G. Ligand modulation of lateral segregation of a G-protein-coupled receptor into lipid microdomains in sphingomyelin/phosphatidylcholine solid-supported bilayers. Biochemistry 44 (2005) 9168-9178
225. Salamon Z., Cowell S., Varga E., Yamamura H.I., Hruby V.J., and Tollin G. Plasmon resonance studies of agonist/antagonist binding to the human δ-opioid receptor: new structural insights into receptor-ligand interactions. Biophys J 79 (2000) 2463-2474
226. Straume M., and Litman B.J. Equilibrium and dynamic bilayer structural properties of unsaturated acyl chain phosphatidylcholine-cholesterol-rhodopsin recombinant vesicles and rod outer segment disk membranes as determined from higher order analysis of fluorescence anisotropy decay. Biochemistry 27 (1988) 7723-7733
227. Mitchell D.C., Straume M., Miller J.L., and Litman B.J. Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids. Biochemistry 29 (1990) 9143-9149
228. Boesze-Battaglia K., and Albert A.D. Cholesterol modulation of photoreceptor function in bovine retinal rod outer segments. J Biol Chem 265 (1990) 20727-20730
229. Albert A.D., Young J.E., and Yeagle P.L. Rhodopsin-cholesterol interactions in bovine rod outer segment disk membranes. Biochim Biophys Acta 1285 (1996) 47-55
230. Attwood P.V., and Gutfreund H. The application of pressure relaxation to the study of the equilibrium between metarhodopsin I and II from bovine retinas. FEBS Lett 119 (1980) 323-326
231. Niu S.L., Mitchell D.C., and Litman B.J. Manipulation of cholesterol levels in rod disk membranes by methyl-β-cyclodextrin: effects on receptor activation. J Biol Chem 277 (2002) 20139-20145
232. Polozova A., and Litman B.J. Cholesterol dependent recruitment of di22:6-PC by a G protein-coupled receptor into lateral domains. Biophys J 79 (2000) 2632-2643
233. Pitman M.C., Grossfield A., Suits F., and Feller S.E. Role of cholesterol and polyunsaturated chains in lipid-protein interactions: molecular dynamics simulation of rhodopsin in a realistic membrane environment. J Am Chem Soc 127 (2005) 4576-4577
234. Boesze-Battaglia K., and Albert A.D. Phospholipid distribution among bovine rod outer segment plasma membrane and disk membranes. Exp Eye Res 54 (1992) 821-823
235. Albert A.D., and Boesze-Battaglia K. The role of cholesterol in rod outer segment membranes. Prog Lipid Res 44 (2005) 99-124
236. Albert A.D., Boesze-Battaglia K., Paw Z., Watts A., and Epand R.M. Effect of cholesterol on rhodopsin stability in disk membranes. Biochim Biophys Acta 1297 (1996) 77-82
237. Kirilovsky J., Steiner-Mordoch S., Selinger Z., and Schramm M. Lipid requirements for reconstitution of the delipidated beta-adrenergic receptor and the regulatory protein. FEBS Lett 183 (1985) 75-80
238. Kirilovsky J., Eimerl S., Steiner-Mordoch S., and Schramm M. Function of the delipidated beta-adrenergic receptor appears to require a fatty acid or a neutral lipid in addition to phospholipids. Eur J Biochem 166 (1987) 221-228
239. Ben-Arie N., Gileadi C., and Schramm M. Interaction of the beta-adrenergic receptor with Gs following delipidation. Specific lipid requirements for Gs activation and GTPase function. Eur J Biochem 176 (1988) 649-654
240. Eroglu C., Cronet P., Panneels V., Beaufils P., and Sinning I. Functional reconstitution of purified metabotropic glutamate receptor expressed in the fly eye. EMBO Rep 3 (2002) 491-496
241. Eroglu C., Brugger B., Wieland F., and Sinning I. Glutamate-binding affinity of Drosophila metabotropic glutamate receptor is modulated by association with lipid rafts. Proc Natl Acad Sci USA 100 (2003) 10219-10224
242. Klein U., Gimpl G., and Fahrenholz F. Alteration of the myometrial plasma membrane cholesterol content with β-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34 (1995) 13784-13793
243. Gimpl G., and Fahrenholz F. Cholesterol as stabilizer of the oxytocin receptor. Biochim Biophys Acta 1564 (2002) 384-392
244. Klein U., and Fahrenholz F. Reconstitution of the myometrial oxytocin receptor into proteoliposomes. Dependence of oxytocin binding on cholesterol. Eur J Biochem 220 (1994) 559-567
245. Gimpl G., Burger K., Politowska E., Ciarkowski J., and Fahrenholz F. Oxytocin receptors and cholesterol: interaction and regulation. Exp Physiol 85 (2000) 41S-49S
246. Harikumar K.G., Puri V., Singh R.D., Hanada K., Pagano R.E., and Miller L.J. Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor. J Biol Chem 280 (2005) 2176-2185
247. Harikumar K.G., Pinon D.I., Wessels W.S., Prendergast F.G., and Miller L.J. Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor. J Biol Chem 277 (2002) 18552-18560
248. Pang L., Graziano M., and Wang S. Membrane cholesterol modulates galanin-GalR2 interaction. Biochemistry 38 (1999) 12003-12011
249. Nguyen D.H., and Taub D. CXCR4 function requires membrane cholesterol: implications for HIV infection. J Immunol 168 (2002) 4121-4126
250. Nguyen D.H., and Taub D. Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. Blood 99 (2002) 4298-4306
251. Nguyen D.H., and Taub D.D. Inhibition of chemokine receptor function by membrane cholesterol oxidation. Exp Cell Res 291 (2003) 36-45
252. Liao Z., Cimakasky L.M., Hampton R., Nguyen D.H., and Hildreth J.E. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 17 (2001) 1009-1019
253. Manes S., del Real G., Lacalle R.A., Lucas P., Gomez-Mouton C., Sanchez-Palomino S., et al. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 1 (2000) 190-196
254. Nguyen D.H., Giri B., Collins G., and Taub D.D. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304 (2005) 559-569
255. Hen R. Of mice and flies: commonalities among 5-HT receptors. Trends Pharmacol Sci 13 (1992) 160-165
256. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev 72 (1992) 165-229
257. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
258. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71 (2002) 533-554
259. Peroutka S.J., and Howell T.A. The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology 33 (1994) 319-324
260. 1A receptor: G protein coupling and signaling pathways. Br J Pharmacol 127 (1999) 1751-1764
261. 1A receptor: a representative member of the serotonin receptor family. Cell Mol Neurobiol 25 (2005) 553-580
262. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., et al. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329 (1987) 75-79
263. 1A receptor. Nature 335 (1988) 358-360
264. 1A receptor is stably palmitoylated, and acylation is critical for communication of receptor with Gi protein. J Biol Chem 279 (2004) 3280-3291
265. 2 adrenergic receptor. Biochemistry 29 (1990) 2335-2342
266. Fraser C.M. Site-directed mutagenesis of β-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation. J Biol Chem 264 (1989) 9266-9270
267. 1A receptor. J Neurochem 56 (1991) 1705-1716
268. 1A receptors from bovine hippocampus. Cell Mol Neurobiol 20 (2000) 665-681
269. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more that 30 years of research. Pharmacol Ther 65 (1995) 319-395
270. 1A antagonists. Trends Neurosci 19 (1996) 378-383
271. Graeff F.G., Guimaraes F.S., de Andrade T.G.C.S., and Deakin J.F.W. Role of 5-HT in stress, anxiety, and depression. Pharmacol Biochem Behav 54 (1996) 129-141
272. 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95 (1998) 14476-14481
273. Rocha B.A., Scearce-Levie K., Lucas J.J., Hiroi N., Castanon N., Crabbe J.C., et al. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 393 (1998) 175-178
274. Meneses A. 5-HT system and cognition. Neurosci Biobehav Rev 23 (1999) 1111-1125
275. 1A receptors in human brain during development. Brain Res Mol Brain Res 60 (1998) 123-126
276. 1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416 (2002) 396-400
277. Gaspar P., Cases O., and Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4 (2003) 1002-1012
278. 1A receptor mutant mice. Proc Natl Acad Sci USA 95 (1998) 15049-15054
279. 1A receptor. Proc Natl Acad Sci USA 95 (1998) 10734-10739
280. Murphy D.L., Wichems C., Li Q., and Heils A. Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission. Trends Pharmacol Sci 20 (1999) 246-252
281. 1A receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem 77 (2001) 607-617
282. Nebigil C.G., and Maroteaux L. A novel role for serotonin in heart. Trends Cardiovasc Med 11 (2001) 329-335
283. Barnes P.J., Chung K.F., and Page C.P. Inflammatory mediators of asthma: an update. Pharmacol Rev 50 (1998) 515-596
284. 1A receptors. Br J Pharmacol 139 (2003) 457-463
285. Locher C.P., Ruben P.C., Gut J., and Rosenthal P.J. 5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel. Antimicrob Agents Chemother 47 (2003) 3806-3809
286. 1A receptor in neuronal cells during prolonged stress and degeneration. J Neurochem 66 (1996) 2361-2372
287. Azmitia E.C. Neuronal instability: implications for Rett's syndrome. Brain Dev 23 Suppl. 1 (2001) S1-S10
288. Blier P., de Montigny C., and Chaput Y. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiat 51 (1990) 14-20
289. 1A receptor blockers as potential drug candidates for the treatment of anxiety disorders. Drug News Perspective 12 (1999) 484-490
290. 1A receptors are increased in postmortem prefrontal cortex in schizophrenia. Brain Res 708 (1996) 209-214
291. 1A receptors and dopamine in blood peripheral lymphocytes of major depression patients. Int Immunopharmacol 3 (2003) 1345-1352
292. 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23 (2003) 8788-8799
293. 1A receptor signaling in brains of suicide victims: involvement of adenylyl cyclase, phosphatidylinositol 3-kinase, Akt and mitogen-activated protein kinase. J Neurochem 87 (2003) 182-194
294. Gingrich J.A., and Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 155 (2001) 1-10
295. Mitchell D.C., Lawrence J.T., and Litman B.J. Primary alcohols modulate the activation of the G protein-coupled receptor rhodopsin by a lipid-mediated mechanism. J Biol Chem 271 (1996) 19033-19036
296. 1B serotonin receptors. Nat Genet 14 (1996) 98-101
297. 2C receptor-mediated phosphoinositide hydrolysis in the brain of alcohol-preferring and alcohol-nonpreferring rats. Alcohol Clin Exp Res 20 (1996) 1038-1042
298. 1A receptors by alcohols. FEBS Lett 438 (1998) 96-100
299. 1A receptors from bovine hippocampus. Brain Res Bull 52 (2000) 597-601
300. q protein function. Mol Pharmacol 59 (2001) 294-301
301. Ishizawa Y., Pidikiti R., Liebman P.A., and Eckenhoff R.G. G protein-coupled receptors as direct targets of inhaled anesthetics. Mol Pharmacol 61 (2002) 945-952
302. 1A receptors from bovine hippocampus with tertiary amine local anesthetics. Cell Mol Neurobiol 24 (2004) 403-422
303. 3H]spiperone discrimates between the G-protein-coupled and -uncoupled forms. Biochem Pharmacol 45 (1993) 1003-1009
304. 125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies. J Pharmacol Exp Ther 272 (1995) 429-437
305. 1A receptors from bovine hippocampus by an agonist and an antagonist. FEBS Lett 457 (1999) 389-392
306. 1A receptors from bovine hippocampus. Biochem Biophys Res Commun 323 (2004) 372-376
307. 1A receptor with G-proteins. Mol Membr Biol 21 (2004) 119-123
308. Haltia T., and Freire E. Forces and factors that contribute to the structural stability of membrane proteins. Biochim Biophys Acta 1228 (1995) 1-27
309. Banerjee P. Detergents. In: Creighton T.E. (Ed). Encyclopedia of molecular biology (1999), Wiley, New York 661-666
310. Garavito R.M., and Ferguson-Miller S. Detergents as tools in membrane biochemistry. J Biol Chem 276 (2001) 32403-32406
311. Chattopadhyay A., and Harikumar K.G. Dependence of critical micelle concentration of a zwitterionic detergent on ionic strength: implications in receptor solubilization. FEBS Lett 391 (1996) 199-202
312. 1A receptors from bovine hippocampus using pre-micellar CHAPS at low concentration. Mol Membr Biol 19 (2002) 211-220
313. 1A receptors heterologously expressed in chinese hamster ovary cells. Cell Mol Neurobiol 24 (2004) 293-300
314. Jones M.B., and Garrison J.C. Instability of the G-protein β5 subunit in detergent. Anal Biochem 268 (1999) 126-133
315. i/o-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation. Mol Pharmacol 57 (2000) 820-825
316. Banerjee P., Dawson G., and Dasgupta A. Enrichment of saturated fatty acid containing phospholipids in sheep brain serotonin receptor preparations: use of microwave irradiation for rapid transesterification of phospholipids. Biochim Biophys Acta 1110 (1992) 65-74
317. 1A receptor with phospholipids containing predominantly saturated fatty acids. Arch Biochem Biophys 305 (1993) 68-77
318. 1A receptor tagged to yellow fluorescent protein. Biochemistry 43 (2004) 15852-15862
319. 1A receptor monitored using fluorescence-based approaches. J Fluoresc 15 (2005) 785-796
320. Lippincott-Schwartz J., Snapp E., and Kenworthy A. Studying protein dynamics in living cells. Nat Rev Mol Cell Biol 2 (2001) 444-456
321. Klonis N., Rug M., Harper I., Wickham M., Cowman A., and Tilley L. Fluorescence photobleaching analysis for the study of cellular dynamics. Eur Biophys J 31 (2002) 36-51
322. Cvejic S., and Devi L.A. Dimerization of the δ opioid receptor: implication for a role in receptor internalization. J Biol Chem 272 (1997) 26959-26964
323. Cheng Z.-J., and Miller L.J. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 276 (2001) 48040-48047
324. Dietschy J.M., and Turley S.D. Cholesterol metabolism in the brain. Curr Opin Lipidol 12 (2001) 105-112
325. Dietschy J.M., and Turley S.D. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45 (2004) 1375-1397
326. Wood W.G., Schroeder F., Avdulov N.A., Chochina S.V., and Igbavboa U. Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease. Lipids 34 (1999) 225-234
327. Waterham H.R., and Wanders R.J.A. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome. Biochim Biophys Acta 1529 (2000) 340-356
328. Papakostas G.I., Öngür D., Iosifescu D.V., Mischoulon D., and Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol 14 (2004) 135-142
329. 1A receptors. Biochim Biophys Acta 1714 (2005) 35-42
330. 1A receptor. Biochem Biophys Res Commun 320 (2004) 557-562
331. 1A receptors. Biochem Biophys Res Commun 331 (2005) 422-427
332. Lentz B.R. Membrane fluidity as detected by diphenylhexatriene probes. Chem Phys Lipids 50 (1989) 171-190
333. Lakowicz J.R. Principles of fluorescence spectroscopy (1999), Kluwer-Plenum Press, New York
334. Prendergast F.G., Haugland R.P., and Callahan P.J. 1-[4-(Trimethylamino) phenyl]-6-phenylhexa-1,3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers. Biochemistry 20 (1981) 7333-7338
335. Sojcic Z., Toplak H., Zuehlke R., Honegger U.E., Buhlmann R., and Wiesmann U.N. Cultured human skin fibroblasts modify their plasma membrane lipid composition and fluidity according to growth temperature suggesting homeoviscous adaptation at hypothermic (30 °C) but not at hyperthermic (40 °C) temperatures. Biochim Biophys Acta 1104 (1992) 31-37
336. Kaiser R.D., and London E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth. Biochemistry 37 (1998) 8180-8190
337. 1A receptors solubilized from bovine hippocampus. Biochem Biophys Res Commun 327 (2005) 1036-1041
338. Eckert G.P., Kirch C., and Mueller W.E. Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient mice. Neuroreport 12 (2001) 883-887
339. Kirsch C., Eckert G.P., and Mueller W.E. Statin effects on cholesterol micro-domains in brain plasma membranes. Biochem Pharmacol 65 (2003) 843-856
340. Steegmans P.H.A., Fekkes D., Hoes A.W., Bak A.A.A., van der Does E., and Grobbee D.E. Low serum cholesterol concentration and serotonin metabolism in men. Br Med J 312 (1996) 221
341. Zureik M., Courbon D., and Ducimetière P. Serum cholesterol concentration and death from suicide in men: Paris prospective study I. Br Med J 313 (1996) 649-651
342. Beasley C.L., Honer W.G., von Bergmann K., Falkai P., Lütjohann D., and Bayer T.A. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord 7 (2005) 449-455
343. Hooper N.M. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae. Mol Membr Biol 16 (1999) 145-156
344. 1A receptor. FEBS Lett 576 (2004) 455-460
345. 1A receptor monitored by detergent insolubility using GFP fluorescence. Mol Membr Biol 22 (2005) 539-547
346. 1A receptors. Biophys J 84 (2003) 522a
347. Barenholz Y. Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications. Subcell Biochem 37 (2004) 167-215
348. Lichtenberg D., Goni F.M., and Heerklotz H. Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem Sci 30 (2005) 430-436